NAD+ vs NMN: Drips and Injections vs the Oral Precursor

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell uses to make energy, and NMN (nicotinamide mononucleotide) is one of the molecules the body turns into it. Clinics sell NAD+ itself by IV drip or injection; supplement makers sell NMN as a capsule. The evidence runs the other way from the price. Oral NMN reliably raises NAD+ in the blood in randomized trials, though its effects on health measures have been mostly small or null.^[1] No outcome trial has tested IV or injected NAD+ for aging or wellness.^[1] Neither is a peptide, and neither is FDA-approved as a drug.

NAD+ vs NMN at a glance

What each one is

NAD+ is a cofactor for enzymes that regulate DNA repair, cell metabolism and immune function.^[3] Both products are sold on the idea that NAD+ levels decline with age and can be topped up. NMN sits one step upstream: cells convert it into NAD+. A third molecule, nicotinamide riboside (NR), is another oral precursor and has been tested in trials alongside NMN.^[1]

The practical difference is the route. NAD+ is a large, charged molecule that clinics give by IV or injection. NMN is swallowed. Across the 33 human studies in a 2026 systematic review, oral NR and NMN “consistently demonstrated biochemical target engagement,” meaning they raised NAD-related molecules in blood or cells, and were generally well tolerated over weeks to months.^[1]

The human evidence for each

NAD+ by IV or injection: no outcome trials

The same review found no eligible outcome trial of IV or intramuscular NAD+ for anti-aging or wellness. The only IV NAD+ study it found was a pharmacokinetic pilot without clinical outcomes.^[1] In that pilot, NAD+ was infused for six hours, and no rise in blood NAD+ or its breakdown products was seen until after the first two hours; the authors reported that NAD+ was “rapidly and completely removed from the plasma” during that time.^[2]

A 2026 retrospective review of records from a commercial clinic compared IV NAD+ with IV NR. People given NAD+ reported moderate to severe stomach symptoms, a faster heart rate and chest pressure, and their infusions took longer, an average of 97 minutes against 37 for NR. The authors were employed by the clinic company.^[3]

NMN by mouth: it raises NAD+, with few clear benefits

NMN has been tested in many small randomized trials. In one of the best known, a 10-week double-blind trial in women past menopause who had prediabetes and excess weight, NMN improved insulin-stimulated glucose uptake into muscle, while placebo did not.^[4] Pooled analyses have mostly been negative:

• Blood sugar and lipids. Eight randomized trials with 342 adults found no significant benefit of NMN on fasting glucose, insulin, HbA1c, insulin resistance or lipids.^[5]
• Muscle in older adults. A 2025 meta-analysis concluded that the evidence “does not support NMN and NR supplementation for preserving muscle mass and function” in adults over 60.^[6]
• Safety and weight. Pooling trials with daily doses from 250 to 2,000 mg, a 2026 meta-analysis saw no rise in liver enzymes and no significant effect on body weight or BMI.^[7]

Oral NMN raises NAD+ and has been tested in people. IV NAD+ is the more expensive option and the less tested one.

Regulatory status side by side

NAD+. NAD+ is not FDA-approved as a drug. FDA’s May 2026 list of substances nominated for 503A compounding puts nicotinamide adenine dinucleotide (NAD), and NADH, in Category 1, substances still under evaluation.^[8] Compounding pharmacies supply NAD+ injections and IV bags on prescription. Being in Category 1 is not an approval and says nothing about whether it works.

NMN. NMN is sold as a dietary supplement. Its status was contested: in 2022 FDA took the position that NMN could not be sold as a supplement because it had first been studied as a drug. On September 29, 2025, FDA posted its response to a citizen petition from the Natural Products Association and the Alliance for Natural Health USA, partly granting it, and concluded that the rule it had relied on does not bar NMN from being a dietary supplement.^[9] Supplements are not reviewed by FDA for effectiveness before sale. The details are in NAD+ and longevity.

The HHS peptide policy. Neither is covered, because the October 28, 2026 HHS policy names six peptides and NAD+ and NMN are not peptides.^[11] Clinics that list NAD+ on a peptide menu are grouping it by marketing, not chemistry. See what is peptide therapy?

In sport. Neither appears on WADA’s Prohibited List. The method matters for NAD+, though: IV infusions or injections of more than 100 mL in a 12-hour period are prohibited, except those legitimately received during hospital treatment, surgery or clinical investigations.^[10] A large NAD+ drip at a wellness clinic can exceed that.

Safety: what is known about each

• IV NAD+. Stomach upset, a racing heart and chest pressure during the infusion, which slow the drip down.^[3] There are no long-term safety data from outcome trials.^[1]
• Oral NMN. Generally well tolerated in trials of weeks to months, with no sign of liver injury in pooled data.^[1][7] Supplement contents are not checked by FDA before sale.
• Both. Most trials are small and short, and several of the NMN trials were run by companies that make it, a point covered in NAD+ and longevity.

Why people combine them

Some clinics pair periodic NAD+ drips with daily oral NMN, on the idea of a loading dose followed by maintenance. No published trial has tested that combination, and with no outcome trial for IV NAD+ alone, there is no evidence that adding the drip does anything that oral precursors do not.^[1] For an approved option against the same goals some clinics sell NAD+ for, such as metabolic health, the GLP-1 drugs are covered in peptides for weight loss.

To check where a peptide or related product stands, use our peptide status checker.